FDA Inspection
American National Red CrossAmerican National Red Cross – FDA Inspection, Dec 7, 2012
Record Details
This FDA Inspection record concerns American National Red Cross, with an inspection on December 7, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- American National Red Cross
- Inspection Date
- December 7, 2012
- Product Type
- Biologics
View Company Profile
ID · 72a9731a-ac72-4b61-8ec5-44bf0bbcaedc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 811101
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
2- 21 CFR 606.160(b)Required records
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of American National Red Cross
7| Date | Classification | Office | Project area |
|---|---|---|---|
| February 11, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 24, 2020 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 19, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 23, 2016 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 6, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for American National Red Cross
- FDA Inspection 1303342 - 2026-02-11
- FDA Inspection 1120997 - 2020-01-24
- FDA Inspection 1028912 - 2017-09-19
- FDA Inspection 987458 - 2016-09-23
- FDA Inspection 882230 - 2014-06-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.